Leidos Life Sciences
Clinical trials sponsored by Leidos Life Sciences, explained in plain language.
A subsidiary of Leidos Holdings, providing research and development services for biomedical and health programs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Heartburn and arthritis drugs tested against COVID-19
Disease control CompletedThis Phase 2 trial tested whether combining famotidine (Pepcid) and celecoxib (Celebrex) could help people with COVID-19 recover faster. Only 4 participants were enrolled, making it too small to draw firm conclusions. The study aimed to see if these drugs could reduce symptom sev…
Phase 2 • Sponsor: Leidos Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Wellness devices show promise for long COVID relief
Symptom relief CompletedThis study tested two wellness products that stimulate the vagus nerve—a key nerve for stress, mood, and inflammation—to see if they could help people with Long COVID. Over 500 participants used the devices and tracked their health with a Fitbit and surveys. The goal was to measu…
Sponsor: Leidos Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC